Sign In

Amgen Inc. (NASDAQ:AMGN)

WEB NEWS

Monday, July 27, 2009

Comments & Business Outlook

Revenues for 2009 are trending towards the upper end of the current guidance range of $14.4 to $14.8 billion. Amgen has increased its previously issued earrings per share guidance range and now expects 2009 adjusted EPS to be in the range of $4.80 to $4.95, an increase from the previous range of $4.55 to $4.75.

FULL YEAR 2009 Guidance Ending December ^a

	Full Year 2009 Guidance	Full Year 2008 Reported	Period Change
GAAP Revenue	$14.4 to $14.8 billion	$15.0 billion	-4.0% to -1.3%
Non-GAAP EPS ^b	$4.80 to $4.95	$4.55	5.5% to 8.8%

Source: See Release, July 27, 2009

^a The above forecasts reflect the Company's current and preliminary views and are therefore subject to change. Please refer to the Company's Safe Harbor Statement (usually in press releases) for the factors that could cause actual results to differ materially from those contained in any forward-looking statement.

^b Non-GAAP EPS figures generally exclude certain non-operating gains and losses as well as certain non-cash items. Non-GAAP information should not be viewed in isolation or as a substitute for reported, or GAAP information . For a more complete explanation of the company's definition of non-GAAP please refer to its financial press releases. The GeoTeam® non-GAAP figures may, from time to time, differ from company supplied figures.

Permalink

Monday, January 26, 2009

Comments & Business Outlook

Guidance Report:

2009 Revenue Guidance	2009 EPS Guidance	*2008 Reported EPS	*Implied EPS Growth Rate
$14.8 to $15.2 billion	$4.55 to $4.75	$4.55	0 to 4.3%

* EPS Figures exclude one time charges and gains (Non-GAAP).

Source: PR Newswire (January 26, 2009)

Permalink